Alprostadil/SEPA - MacroChem

Drug Profile

Alprostadil/SEPA - MacroChem

Alternative Names: Prostaglandin E1/SEPA - MacroChem; Topiglan

Latest Information Update: 29 Jun 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator MacroChem
  • Class Erectile dysfunction therapies; Monounsaturated fatty acids; Muscle relaxants; Peripheral vasodilators; Prostaglandins; Small molecules
  • Mechanism of Action Prostaglandin E1 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Erectile dysfunction

Most Recent Events

  • 23 Jun 2004 Discontinued - Phase-II for Erectile dysfunction in United Kingdom (Topical)
  • 23 Jun 2004 Discontinued - Phase-II for Erectile dysfunction in USA (Topical)
  • 19 Apr 2004 Data from a media release have been added to the Mens Health therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top